Clinical Trial Update: Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections [NA]

View source ↗

Summary

A clinical trial to determine whether intranasal mupirocin reduces Staphylococcus aureus surgical site infections after cesarean sections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection
• Surgical Site Infection

Drugs mentioned

• Bactroban (mupirocin)

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Surgical Wound Infection, Cesarean Section | NA | Status: UNKNOWN